Home
Citadel Advisors reported a 5.5% stake in Acrivon Therapeutics ACRV · 1,721,867 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.5%
- Last report
- 4.9% · filed 25/11/14
- Shares held
- 1,721,867 sh
- Class
- Common Stock, par value $0.001 per share (the "Shares")
- Holder
- Citadel Advisors
- Event date
- 25/11/14
- Filed
- 25/11/21
5.5% stake · +0.6pp from the last report
- Stake
- 5.5%
- Last report
- 4.9%
- Since last report
- +0.6pp
Acrivon Therapeutics trades, last 26 weeks
What else happened in Acrivon Therapeutics around then
Filed or reported within 30 days of the trade day · 25/10/15~25/12/14Citadel Advisors's other 5% stake reports
- Citadel Advisors
5% stakeVenu Holding
5% stakeVenu Holding
VENU
3.8% stake
2,365,505 sh
3.8% stake
Filed 08/14
- Citadel Advisors
5% stakeSpruce Biosciences
5% stakeSpruce Biosciences
SPRB
1.9% stake
51,919 sh
1.9% stake
Filed 08/14
- Citadel Advisors
5% stakeMomentus
5% stakeMomentus
MNTS
1.6% stake
309,865 sh
1.6% stake
Filed 08/14
- Citadel Advisors
5% stakeXCHG
5% stakeXCHG
XCH
9.7% stake
272,656,440 sh
9.7% stake
Filed 08/14
- Citadel Advisors
5% stakeVillage Farms International
5% stakeVillage Farms International
VFF
5.5% stake
6,689,240 sh
5.5% stake
Filed 08/14
